nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE4A—autistic disorder	0.427	0.546	CbGaD
Pentoxifylline—PDE4B—autistic disorder	0.354	0.454	CbGaD
Pentoxifylline—NT5E—eye—autistic disorder	0.00311	0.0488	CbGeAlD
Pentoxifylline—NT5E—telencephalon—autistic disorder	0.00284	0.0445	CbGeAlD
Pentoxifylline—ADORA2B—eye—autistic disorder	0.00267	0.0418	CbGeAlD
Pentoxifylline—ADORA2A—forebrain—autistic disorder	0.0022	0.0345	CbGeAlD
Pentoxifylline—PDE4A—telencephalon—autistic disorder	0.00217	0.034	CbGeAlD
Pentoxifylline—ADORA2A—telencephalon—autistic disorder	0.00202	0.0317	CbGeAlD
Pentoxifylline—PDE5A—eye—autistic disorder	0.00202	0.0317	CbGeAlD
Pentoxifylline—PDE5A—forebrain—autistic disorder	0.002	0.0314	CbGeAlD
Pentoxifylline—ADORA1—forebrain—autistic disorder	0.0019	0.0298	CbGeAlD
Pentoxifylline—PDE5A—telencephalon—autistic disorder	0.00184	0.0289	CbGeAlD
Pentoxifylline—NT5E—head—autistic disorder	0.00177	0.0277	CbGeAlD
Pentoxifylline—ADORA1—telencephalon—autistic disorder	0.00175	0.0274	CbGeAlD
Pentoxifylline—Theobromine—PDE4B—autistic disorder	0.00169	0.319	CrCbGaD
Pentoxifylline—NT5E—nervous system—autistic disorder	0.00168	0.0263	CbGeAlD
Pentoxifylline—NT5E—central nervous system—autistic disorder	0.00161	0.0253	CbGeAlD
Pentoxifylline—ADORA2B—head—autistic disorder	0.00151	0.0237	CbGeAlD
Pentoxifylline—Dyphylline—PDE4A—autistic disorder	0.00149	0.283	CrCbGaD
Pentoxifylline—ADORA2B—nervous system—autistic disorder	0.00143	0.0225	CbGeAlD
Pentoxifylline—PDE5A—digestive system—autistic disorder	0.00141	0.0221	CbGeAlD
Pentoxifylline—PDE4B—forebrain—autistic disorder	0.0014	0.022	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—autistic disorder	0.00138	0.0217	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—autistic disorder	0.00135	0.0212	CbGeAlD
Pentoxifylline—PDE4B—telencephalon—autistic disorder	0.00129	0.0203	CbGeAlD
Pentoxifylline—NT5E—brain—autistic disorder	0.00128	0.0201	CbGeAlD
Pentoxifylline—ADORA2A—head—autistic disorder	0.00126	0.0198	CbGeAlD
Pentoxifylline—Dyphylline—PDE4B—autistic disorder	0.00124	0.234	CrCbGaD
Pentoxifylline—PDE4A—cerebellum—autistic disorder	0.0012	0.0189	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—autistic disorder	0.00119	0.0187	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—autistic disorder	0.00115	0.018	CbGeAlD
Pentoxifylline—PDE5A—head—autistic disorder	0.00115	0.018	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—autistic disorder	0.00112	0.0176	CbGeAlD
Pentoxifylline—ADORA2B—brain—autistic disorder	0.0011	0.0172	CbGeAlD
Pentoxifylline—PDE5A—nervous system—autistic disorder	0.00109	0.0171	CbGeAlD
Pentoxifylline—ADORA1—head—autistic disorder	0.00109	0.0171	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—autistic disorder	0.00105	0.0164	CbGeAlD
Pentoxifylline—ADORA1—nervous system—autistic disorder	0.00103	0.0162	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—autistic disorder	0.00102	0.016	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—autistic disorder	0.000992	0.0156	CbGeAlD
Pentoxifylline—PDE4A—brain—autistic disorder	0.000977	0.0153	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—autistic disorder	0.00097	0.0152	CbGeAlD
Pentoxifylline—ADORA2A—brain—autistic disorder	0.000912	0.0143	CbGeAlD
Pentoxifylline—Caffeine—PDE4B—autistic disorder	0.000866	0.164	CrCbGaD
Pentoxifylline—PDE5A—brain—autistic disorder	0.000831	0.013	CbGeAlD
Pentoxifylline—PDE4B—head—autistic disorder	0.000804	0.0126	CbGeAlD
Pentoxifylline—ADORA1—brain—autistic disorder	0.000788	0.0124	CbGeAlD
Pentoxifylline—PDE4B—nervous system—autistic disorder	0.000762	0.012	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—autistic disorder	0.000734	0.0115	CbGeAlD
Pentoxifylline—PDE4B—cerebellum—autistic disorder	0.000717	0.0113	CbGeAlD
Pentoxifylline—CYP1A2—digestive system—autistic disorder	0.000605	0.0095	CbGeAlD
Pentoxifylline—PDE4B—brain—autistic disorder	0.000583	0.00914	CbGeAlD
Pentoxifylline—ADORA1—GPCR downstream signaling—PRKCB—autistic disorder	2.35e-05	0.000156	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CALCA—autistic disorder	2.35e-05	0.000156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD1—autistic disorder	2.35e-05	0.000156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSC1—autistic disorder	2.35e-05	0.000156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MAPK1—autistic disorder	2.34e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—autistic disorder	2.33e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GABBR1—autistic disorder	2.32e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADM—autistic disorder	2.32e-05	0.000155	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PRKCB—autistic disorder	2.32e-05	0.000155	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSC1—autistic disorder	2.32e-05	0.000154	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD1—autistic disorder	2.32e-05	0.000154	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	2.31e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—POMC—autistic disorder	2.29e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—POMC—autistic disorder	2.29e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EIF4E—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRL—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTRK2—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PRKCB—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ACADSB—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INPP1—autistic disorder	2.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD3—autistic disorder	2.27e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDE4B—autistic disorder	2.26e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AVP—autistic disorder	2.26e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTRK2—autistic disorder	2.25e-05	0.00015	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CG—autistic disorder	2.25e-05	0.00015	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	2.25e-05	0.000149	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD3—autistic disorder	2.24e-05	0.000149	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CG—autistic disorder	2.22e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL5—autistic disorder	2.22e-05	0.000148	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTEN—autistic disorder	2.22e-05	0.000148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL5—autistic disorder	2.2e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CALCA—autistic disorder	2.2e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—OPRM1—autistic disorder	2.19e-05	0.000146	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CG—autistic disorder	2.18e-05	0.000145	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CALCA—autistic disorder	2.17e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB2—autistic disorder	2.16e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—autistic disorder	2.14e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PRKCB—autistic disorder	2.14e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PLA2G4A—autistic disorder	2.12e-05	0.000141	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—autistic disorder	2.12e-05	0.000141	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PRKCB—autistic disorder	2.11e-05	0.00014	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—autistic disorder	2.08e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRL—autistic disorder	2.07e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—autistic disorder	2.07e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CG—autistic disorder	2.04e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AVP—autistic disorder	2.03e-05	0.000135	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BTD—autistic disorder	2.03e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—autistic disorder	2.02e-05	0.000135	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CG—autistic disorder	2.02e-05	0.000134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GZMB—autistic disorder	2.01e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB2—autistic disorder	1.97e-05	0.000131	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—OXT—autistic disorder	1.95e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR1B—autistic disorder	1.95e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—autistic disorder	1.94e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRL—autistic disorder	1.94e-05	0.000129	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	1.94e-05	0.000129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—autistic disorder	1.92e-05	0.000128	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRL—autistic disorder	1.92e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PLA2G4A—autistic disorder	1.91e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—autistic disorder	1.88e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—autistic disorder	1.88e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—autistic disorder	1.86e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MEF2C—autistic disorder	1.86e-05	0.000124	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AVP—autistic disorder	1.85e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB2—autistic disorder	1.84e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—autistic disorder	1.84e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB2—autistic disorder	1.82e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PRKCB—autistic disorder	1.82e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ITGB3—autistic disorder	1.81e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD1—autistic disorder	1.81e-05	0.00012	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC1—autistic disorder	1.81e-05	0.00012	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—autistic disorder	1.79e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK2—autistic disorder	1.76e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD3—autistic disorder	1.75e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CG—autistic disorder	1.74e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PLA2G4A—autistic disorder	1.74e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AVP—autistic disorder	1.73e-05	0.000115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TDO2—autistic disorder	1.73e-05	0.000115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—autistic disorder	1.72e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—autistic disorder	1.72e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL5—autistic disorder	1.72e-05	0.000114	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AVP—autistic disorder	1.71e-05	0.000114	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—autistic disorder	1.7e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CALCA—autistic disorder	1.7e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—autistic disorder	1.69e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—autistic disorder	1.69e-05	0.000113	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—autistic disorder	1.69e-05	0.000113	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MEF2C—autistic disorder	1.69e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—autistic disorder	1.65e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PRKCB—autistic disorder	1.65e-05	0.00011	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ITGB3—autistic disorder	1.65e-05	0.000109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PLA2G4A—autistic disorder	1.63e-05	0.000108	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DHCR7—autistic disorder	1.62e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSC2—autistic disorder	1.61e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PLA2G4A—autistic disorder	1.61e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—autistic disorder	1.58e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MEF2C—autistic disorder	1.58e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CG—autistic disorder	1.58e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—autistic disorder	1.57e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—autistic disorder	1.57e-05	0.000105	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—autistic disorder	1.56e-05	0.000104	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MEF2C—autistic disorder	1.56e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ITGB3—autistic disorder	1.54e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC6A8—autistic disorder	1.54e-05	0.000102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EXT1—autistic disorder	1.54e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—autistic disorder	1.54e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—autistic disorder	1.54e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ITGB3—autistic disorder	1.52e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—autistic disorder	1.5e-05	9.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRL—autistic disorder	1.5e-05	9.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRKCB—autistic disorder	1.48e-05	9.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DAO—autistic disorder	1.47e-05	9.77e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSC2—autistic disorder	1.46e-05	9.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—autistic disorder	1.44e-05	9.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—autistic disorder	1.44e-05	9.57e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—autistic disorder	1.43e-05	9.5e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—autistic disorder	1.43e-05	9.5e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—autistic disorder	1.42e-05	9.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB2—autistic disorder	1.42e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—autistic disorder	1.42e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—autistic disorder	1.42e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—autistic disorder	1.42e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—UPB1—autistic disorder	1.41e-05	9.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGF—autistic disorder	1.4e-05	9.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSC2—autistic disorder	1.37e-05	9.09e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—autistic disorder	1.35e-05	8.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSC2—autistic disorder	1.35e-05	8.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRKCB—autistic disorder	1.35e-05	8.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—autistic disorder	1.34e-05	8.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—autistic disorder	1.34e-05	8.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AVP—autistic disorder	1.33e-05	8.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—autistic disorder	1.33e-05	8.84e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—autistic disorder	1.32e-05	8.79e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—autistic disorder	1.32e-05	8.79e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM5—autistic disorder	1.31e-05	8.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ASMT—autistic disorder	1.31e-05	8.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—autistic disorder	1.3e-05	8.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK1—autistic disorder	1.29e-05	8.61e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—autistic disorder	1.29e-05	8.58e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—autistic disorder	1.29e-05	8.58e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGF—autistic disorder	1.27e-05	8.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRKCB—autistic disorder	1.26e-05	8.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLA2G4A—autistic disorder	1.26e-05	8.35e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRKCB—autistic disorder	1.25e-05	8.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—autistic disorder	1.23e-05	8.21e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC25A12—autistic disorder	1.23e-05	8.19e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—autistic disorder	1.23e-05	8.16e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—autistic disorder	1.22e-05	8.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MEF2C—autistic disorder	1.22e-05	8.12e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—autistic disorder	1.21e-05	8.03e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—autistic disorder	1.21e-05	8.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC19A1—autistic disorder	1.2e-05	7.97e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGF—autistic disorder	1.19e-05	7.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—autistic disorder	1.19e-05	7.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—autistic disorder	1.19e-05	7.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ITGB3—autistic disorder	1.19e-05	7.92e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—autistic disorder	1.18e-05	7.85e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGF—autistic disorder	1.18e-05	7.84e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK1—autistic disorder	1.17e-05	7.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—autistic disorder	1.15e-05	7.64e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—autistic disorder	1.14e-05	7.55e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—autistic disorder	1.12e-05	7.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—autistic disorder	1.11e-05	7.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—autistic disorder	1.11e-05	7.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—autistic disorder	1.11e-05	7.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.1e-05	7.32e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK1—autistic disorder	1.1e-05	7.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—autistic disorder	1.09e-05	7.27e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK1—autistic disorder	1.09e-05	7.23e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADSL—autistic disorder	1.07e-05	7.1e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC2—autistic disorder	1.06e-05	7.02e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—autistic disorder	1.05e-05	6.98e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—XDH—autistic disorder	1.05e-05	6.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—autistic disorder	1.04e-05	6.91e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—autistic disorder	1.04e-05	6.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—autistic disorder	1.03e-05	6.87e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—autistic disorder	1.03e-05	6.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STX1A—autistic disorder	1.03e-05	6.83e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NPAS2—autistic disorder	1.03e-05	6.83e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—autistic disorder	9.99e-06	6.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—autistic disorder	9.94e-06	6.61e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TCN2—autistic disorder	9.92e-06	6.6e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCB—autistic disorder	9.74e-06	6.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADA—autistic disorder	9.46e-06	6.3e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—autistic disorder	9.43e-06	6.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—autistic disorder	9.4e-06	6.25e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	9.35e-06	6.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—autistic disorder	9.32e-06	6.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—autistic disorder	9.32e-06	6.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGF—autistic disorder	9.21e-06	6.13e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—autistic disorder	9.07e-06	6.04e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—autistic disorder	9.03e-06	6.01e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	8.96e-06	5.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—autistic disorder	8.87e-06	5.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—autistic disorder	8.83e-06	5.88e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—autistic disorder	8.73e-06	5.81e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RORA—autistic disorder	8.63e-06	5.74e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—autistic disorder	8.53e-06	5.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—autistic disorder	8.53e-06	5.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—autistic disorder	8.49e-06	5.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK1—autistic disorder	8.49e-06	5.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—autistic disorder	8.45e-06	5.62e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—autistic disorder	8.39e-06	5.58e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—autistic disorder	8.35e-06	5.56e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—autistic disorder	8.1e-06	5.39e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOB—autistic disorder	8.09e-06	5.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—autistic disorder	7.99e-06	5.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—autistic disorder	7.9e-06	5.25e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	7.7e-06	5.12e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK1—autistic disorder	7.64e-06	5.08e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPH2—autistic disorder	7.52e-06	5e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DPYD—autistic disorder	7.4e-06	4.92e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	6.95e-06	4.62e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK1—autistic disorder	6.94e-06	4.62e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNA1C—autistic disorder	6.88e-06	4.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—autistic disorder	6.82e-06	4.54e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	6.61e-06	4.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—autistic disorder	6.56e-06	4.36e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—autistic disorder	6.53e-06	4.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK1—autistic disorder	6.5e-06	4.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK1—autistic disorder	6.42e-06	4.27e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DHFR—autistic disorder	6.26e-06	4.16e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—autistic disorder	6.17e-06	4.11e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—autistic disorder	6.13e-06	4.08e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—autistic disorder	5.87e-06	3.91e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—autistic disorder	5.57e-06	3.71e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—autistic disorder	5.33e-06	3.55e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	5.27e-06	3.51e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—autistic disorder	5.22e-06	3.47e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—autistic disorder	5.15e-06	3.43e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK1—autistic disorder	5.02e-06	3.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—autistic disorder	4.99e-06	3.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—autistic disorder	4.93e-06	3.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP19A1—autistic disorder	4.9e-06	3.26e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.6e-06	3.06e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COMT—autistic disorder	4.55e-06	3.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—autistic disorder	4.53e-06	3.02e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOA—autistic disorder	4.52e-06	3.01e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAT—autistic disorder	4.41e-06	2.94e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—autistic disorder	4.17e-06	2.77e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLA2G4A—autistic disorder	4.17e-06	2.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—autistic disorder	4.03e-06	2.68e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX1—autistic disorder	3.99e-06	2.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—autistic disorder	3.85e-06	2.56e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—autistic disorder	3.68e-06	2.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—autistic disorder	3.43e-06	2.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—autistic disorder	3.09e-06	2.06e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—autistic disorder	2.94e-06	1.96e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—autistic disorder	2.35e-06	1.56e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—autistic disorder	2.05e-06	1.36e-05	CbGpPWpGaD
